23229-26-7 Usage
General Description
2,5-Dibromopyrazine is a chemical compound categorized under the chemical class called pyrazines - a group of heterocyclic aromatic organic compounds. This off-white crystalline powder is mainly known for its extensive use in chemical industries and laboratories for conducting numerous organic reactions such as amination, acylation, urea bond formation, and others. Additionally, this compound has a unique aromatic nature with two bromine substitutions which increases its reactivity compared to other pyrazines. It has a molecular weight of 252.93 g/mol, and the chemical formula C4H2Br2N2. The compound is quite stable in normal conditions, but it may pose certain hazards if not handled or disposed of properly.
Check Digit Verification of cas no
The CAS Registry Mumber 23229-26-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,2,2 and 9 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 23229-26:
(7*2)+(6*3)+(5*2)+(4*2)+(3*9)+(2*2)+(1*6)=87
87 % 10 = 7
So 23229-26-7 is a valid CAS Registry Number.
InChI:InChI=1/C4H2Br2N2/c5-3-1-7-4(6)2-8-3/h1-2H
23229-26-7Relevant articles and documents
Structure property relationship of linear and angular pyrazine-based structural isomers with terminal D-A groups and evaluation of their photophysical properties
Meti, Puttavva,Park, Dong-Jin,Gong, Young-Dae
, p. 357 - 368 (2019)
A series of pyrazine-based linear and angular shaped push-pull chromophores were synthesized by Sonogashira reaction and were further investigated by X-ray analysis. The photophysical properties were comprehensively studied both experimentally and through
NOVEL COMPOUNDS AS GPR119 AGONISTS
-
Paragraph 0592-0594, (2017/10/26)
The present invention relates to novel compounds of formula (I) as GPR119 agonist, composition compositions containing such compounds and method of preparation thereof.
BENZO ‘ D!AZEPINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
-
Page/Page column 24-25, (2010/02/07)
The present invention relates to benzazepine derivatives of formula ( I ) wherein: R1 represents -C3-7 cycloalkyl optionally substituted by C1-3 alkyl; having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
